Generic Name: toremifene

Pronunciation: N/A

Abbreviation: N/A

Other Market Name: N/A

Drug Class: Hormone Therapy Medications

Company: Kyowa Kirin

Approval Status: Approved

Generic Version Available: No

Experimental Code: N/A

Drug Indication

Fareston is a selective estrogen receptor modulator approved for the treatment of metastatic breast cancer in postmenopausal women with estrogen receptor-positive tumors or those with unknown receptor status.

General Info

The female hormone estrogen promotes the growth of estrogen receptor-positive breast cancer. Evista works blocking these receptors and preventing estrogen from binding to cancer cells. It has selective activity against breast cancer while having estrogen-like activity elsewhere in the body.


Dosing Info:

Fareston is taken as a once-daily tablet.

Side Effects

Common side effects include hot flashes, nausea and vaginal dryness or discharge. Potential serious side effects may include heart rhythm abnormalities, liver toxicity and increased risk of uterine cancer. Fareston should not be used during pregnancy.

For More Info:

Last Reviewed: December 6, 2018